Buprenorphine And Naloxone Tablet
Product Images NDC 62756-969

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 62756-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-buprenorphine-naloxone-label-1 (Spl Buprenorphine Naloxone Label 1)

Label for Buprenorphine and Naloxone Sublingual Tablets 2 mg/0.5 mg, by Sun Pharmaceutical Industries, Inc. The label indicates a 30 tablet count with storage instructions, dosage references, and warnings about accidental ingestion by children. It includes barcode and distributor and manufacturer information from Sun Pharmaceutical Industries Ltd.*

FDA Label Image

Spl-buprenorphine-naloxone-label-2 (Spl Buprenorphine Naloxone Label 2)

Label for Buprenorphine and Naloxone Sublingual Tablets, 8 mg/2 mg strength, marketed by Sun Pharmaceutical Industries, Inc. The label indicates a package of 30 tablets, with storage instructions, a warning about accidental ingestion by children, and directions to dispense with a Medication Guide. The label includes manufacturer and distributor information, a barcode, and dosage details.*

FDA Label Image

Spl-buprenorphine-structure (Spl Buprenorphine Structure)

Chemical structure of Buprenorphine and Naloxone with hydrochloride (HCl) indicated, showing the detailed molecular arrangement of the active ingredients.*

FDA Label Image

Spl-figure (Spl Figure)

An illustration showing a person placing a tablet under their tongue, demonstrating the sublingual administration route for a tablet dosage form.*

FDA Label Image

Spl-naloxone-structure (Spl Naloxone Structure)

Chemical structure of the active ingredient Buprenorphine, showing its molecular configuration including hydroxyl, ketone, and nitrogen-containing groups, with labeling indicating the presence of hydrochloride and dihydrate (HCl • 2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.